when switching from semaglutide to tirzepatide Switching between weight-loss medications -

How is an LSA set up

The 2023 SURMOUNT-1 trial tested tirzepatide at 5 mg, 10 mg, and 15 mg weekly doses but did not include split-dosing arms (Jastreboff et al., NEJM 2022)

Communicate with patients proactively

Plant Physiology 186, 110124

Health Canada has issued a public advisory warning Canadians against buying unauthorized or counterfeit GLP-1 receptor agonist products, saying it has identified retailers selling such products both in stores and online [Source: newswire.ca/news-releases/public-advisory-thinking-about-buying-glp-1-drugs-like-ozempic-or-mounjaro-beware-of-fake-or-unauthorized-products-844970747.html]

Sherman B, et al